Endocrine (Hormonal) Therapies for Breast Cancer

Follow the links below to find information on hormonal treatments for breast cancer.

Reviewed September 2008

Printer friendly page

17 Resources Found
Results 1 to 17 displayed.
Title:   Hormone Replacement Therapy (HRT) and risk of breast cancer - NBOCC Position statement
Publisher:   National Breast and Ovarian Cancer Centre (NBOCC)
Description:   For the purposes of this position statement, the National Breast and Ovarian Cancer Centre (NBOCC) defines HRT as the use of exogenous hormones (eg oestrogens, progestogen, testosterone) to manage menopausal symptoms.
Date:   Sep 2009
Title:   Deciding about hormonal therapies
Publisher:   National Breast and Ovarian Cancer Centre
Description:   When deciding about hormonal therapies it's important to consider the likely benefits and possible side effects of the different treatments.
Date:   Sep 2009
Title:   Types of hormonal therapy
Publisher:   National Breast and Ovarian Cancer Centre
Description:   There are different types of hormonal therapy for breast cancer. The type of hormonal therapy recommended for women with hormone receptor-positive breast cancer depends on whether the woman has reached menopause.
Date:   Sep 2009
Title:   Hormonal therapies
Publisher:   National Breast and Ovarian Cancer Centre
Description:   Hormonal therapies are treatments for women who have hormone receptors on their breast cancer cells.
Date:   Sep 2009
Title:   Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Tamoxifen is commonly used by women to reduce the risk of breast cancer recurrence. Tamoxifen can also cause abnormal changes to the lining of the womb (endometrium), including polyps and cancer. Mirena is a uterine device that releases the progesterone...
Date:   Aug 2009
Title:   Side effects of hormonal therapies
Publisher:   National Breast and Ovarian Cancer Centre
Description:   Some side effects are common to all hormonal therapies, and some only happen with certain therapies.
Date:   Jul 2009
Title:   ETAG recommendations for endocrine therapy treatment of hormone receptor-positive advanced breast cancer
Publisher:   National Breast and Ovarian Cancer Centre (NBOCC)
Description:   A clinical practice guideline developed by NBOCC. This document supplements guideline recommendations 22, 24a and 24b about the use of endocrine therapy in National Breast Cancer Centre (NBCC) Clinical Practice Guidelines for the Management of Advanced Breast Cancer, 2nd edition, 2001 (page 9).
Date:   May 2009
Title:   LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   To assess LHRH agonists as adjuvant therapy for women with early breast cancer.
Date:   Oct 2008
Title:   Diethylstilboestrol (DES)- alerts & advisories
Publisher:   Australian Government Department of Health and Ageing
Description:   Links to alerts and advisory statements about Diethylstilboestrol (DES)
Date:   Apr 2008
Title:   Screening guidelines for women exposed in utero to diethylstilboestrol (DES)
Publisher:   Australian Government Department of Health and Ageing
Description:   Diethylstilboestrol, or DES (also known as stilboestrol), is a synthetic oestrogen which was used between 1940 and the early 1970s to prevent miscarriage in women with a previous poor pregnancy outcome.
Date:   Apr 2008
Title:   Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   While younger women with early-stage breast cancer almost invariably are treated with surgery plus endocrine therapy, (which deprives the cancer of hormones which induce growth of the cancer), women over the age of 70yrs are frequently offered endocrine...
Date:   Nov 2007
Title:   Breast cancer and oestrogen
Publisher:   Better Health Channel
Description:   Oestrogen affects some breast cancers. These cancers are called receptor positive cancers. Medications such as tamoxifen can block the action of oestrogen and prevent it stimulating breast cancer cells. Menstruating women who have hormone responsive breast cancer can benefit from hormone therapy. Women taking hormone replacement therapy (HRT) may have a higher risk of some breast cancers.
Date:   Oct 2007
Title:   Phytoestrogens and breast cancer
Publisher:   The Jean Hailes Foundation for Women's Health
Description:   There has been much speculation about phytoestrogens - particularly soy products, and breast cancer risk. This is mainly based on the idea that because these foods contain oestrogen, they can stimulate the breast tissue like our own body's oestrogen or prescribed oestrogen might.
Date:   Oct 2007
Title:   Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Breast cancer is the most common cancer in women. If the cancer has spread beyond the breast (metastatic disease), treatments include chemotherapy (anti-cancer drugs) and endocrine therapy (also known as hormonal treatment). Endocrine therapy is mainly ...
Date:   Aug 2006
Title:   Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Advanced (or metastatic) breast cancer is cancer that has spread beyond the breast. Endocrine therapy removes the influence of oestrogen on breast cancer cells and can prevent the cells from growing and spreading in early breast cancer if the tumour is ...
Date:   Sep 2005
Title:   New hope for advanced breast cancer - myDr.com.au
Publisher:   myDr
Description:   A study has brought some good news to postmenopausal women with advanced breast cancer.
Date:   Jul 2001
Title:   Clinical practice guidelines for the management of advanced breast cancer
Publisher:   National Health and Medical Research Council (NHMRC)
Description:   These guidelines have been developed by a multidisciplinary working party, and are primarily intended for use by all health professionals involved in the management of women with advanced breast cancer. They aim to provide material that will be helpful and supportive to those managing the difficult range of problems that may present.
Date:   Jan 2001
Results 1 to 17 displayed.